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Abstract 1 
Surfaces within healthcare play a key role in the transmission of drug-resistant 2 
pathogens. Candida auris is an emerging multi-drug resistant yeast which has 3 
the ability to survive for prolonged periods on environmental surfaces. Here we 4 
show that the ability to form cellular aggregates increases survival after 14 days, 5 
which coincides with the upregulation of biofilm-associated genes. Additionally, 6 
the aggregating strain demonstrated tolerance to clinical concentrations of 7 
sodium hypochlorite and remain viable 14 days’ post treatment. The ability of C. 8 
auris to adhere and persist on environmental surfaces emphasises our need to 9 
better understand the biology of this fungal pathogen.  10 
 11 
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Introduction 1 
Since its discovery in 2009, Candida auris has quickly emerged as a prolific 2 
nosocomial pathogen, responsible for a number of simultaneous outbreaks 3 
globally [1]. It is of considerable interest given the difficulties associated with 4 
identifying and treating this organism and its association with life-threatening 5 
infections and high mortality rates. 6 
 7 
A key attribute of its pathogenic repertoire is its ability to survive and persist in 8 
the environment, yet the methods employed by this multi-drug resistant 9 
pathogen to disseminate throughout healthcare environments are still not fully 10 
understood. This has profound implications for decontamination and infection 11 
control protocols. Therefore, understanding the mechanisms of spread and 12 
survival in the hospital environment is critical, particularly as it is able to persist 13 
on hospital fomites, extensively colonise individuals and also survive as biofilms 14 
[2, 3]. Although traditionally biofilms are associated with formation on an 15 
indwelling medical device or on a mucosal substrate, recent investigations have 16 
suggested that these communities can facilitate residence and survival upon 17 
surfaces within a clinical setting [4].  18 
 19 
Despite the obvious lack of nutrients, these communities adapt to survive and 20 
display increased tolerance to both heat and conventional disinfection 21 
treatments compared to a free floating, equivalent cell [5]. C. auris has been 22 
shown to readily transmit between hospital equipment, such as reusable 23 
temperature probes, and patients suggesting limitations of current infection 24 
control strategies [4]. Commonly used disinfectants have been shown to be 25 
highly effective when tested in suspension, yet our previous data indicates that 26 
adherent C. auris cells can selectively tolerate biocides including sodium 27 
hypochlorite and peracetic acid, in a substrate dependent manner [2].  28 
 29 
Given the lack of knowledge of survival strategies utilised by C. auris, and the 30 
identification of phenotypically distinct morphologies of single celled and 31 
aggregating isolates by Borman and co-workers [6], we herein investigated the 32 
potential of these phenotypic traits of biofilm formation and cellular aggregation 33 
that may aid environmental persistence and survival.  34 
35 
 4 
Material and Methods 1 
Microbial growth and standardisation 2 
C. auris clinical isolates NCPF 8973 (single cells) and NCPF 8978 (aggregates) 3 
were used throughout this study, with phenotypes determined visually using 4 
microscopy as previously described [6]. For survival experiments, Candida 5 
glabrata ATCC 2001 and Candida parapsilosis NCPF 8334 were used as 6 
reference species. All strains were stored and maintained on Sabouraud 7 
dextrose (SAB) agar (Oxoid, Hampshire, UK) at 4˚C prior to propagation in yeast 8 
peptone dextrose (YPD; Sigma-Aldrich, Dorset, UK) medium overnight at 30˚C. 9 
Cells were washed by centrifugation in phosphate buffered saline (PBS; Sigma-10 
Aldrich), and standardised to desired concentration in selected media after 11 
counting using a haemocytometer.  12 
 13 
Fungal survival assay 14 
To assess the persistence of Candida species on dry, non-porous substrates 15 
methods were adapted from Welsh et al (2017) with slight modifications [7]. To 16 
simulate microbial spillages within the nosocomial environment, various growth 17 
conditions were used: PBS, artificial saliva (AS) and 10% fetal calf serum (FCS; 18 
Sigma-Aldrich, Dorset, UK). Cells were grown and standardised as described 19 
above to 1x108 cells/mL in selected media. Standardised cell suspensions were 20 
added to ThermanoxTM cover slips (Fisher Scientific, Loughborough, UK) and 21 
allowed to adhere for 90 minutes before removing media and washing to remove 22 
non-adherent cells. Following washing, biomass was subsequently removed 23 
from the cover slips via sonication in 1mL PBS in an ultrasonic water bath (Fisher 24 
Scientific, Loughborough, UK) at 35kHz for 10 minutes, defined as Day 0. In 25 
addition, cells were also maintained at ambient temperature for a period of 14 26 
days after initial adherence. Following growth and sonication, biomass was 27 
serially diluted for viable cell quantification using the miles and misra colony 28 
counting technique. 29 
 30 
Fluorescent Imaging 31 
For microscopic analysis, dry biofilms were prepared for 14 days as described 32 
above. Following incubation, biofilms were stained with FUN-1 dye (20µM 33 
[ThermoScientific, Loughborough, UK]). The dye was added to the biofilms and 34 
 5 
incubated in the dark at 37˚C for 30 minutes. Following staining, biofilms were 1 
washed 3 times with PBS, before images were captured and processed using 2 
an EVOS fluorescent microscope (ThermoScientific, Loughborough, UK). 3 
 4 
Transcriptional analysis 5 
C. auris cells were grown as described above and RNA was extracted as 6 
described previously [8]. In brief, cells were removed from substrates by 7 
sonication, before being homogenized using a bead beater and RNA extracted 8 
using the TRIzol™ method. Following clean up with the RNeasy minikit (Qiagen, 9 
Crawley, UK), cDNA was synthesized using the High Capacity RNA to cDNA kit 10 
(Life Technologies, Paisley, UK) as per the manufacturer’s instructions. All 11 
primer sequences used for quantitative polymerase chain reaction (qPCR) are 12 
shown in supplementary Table 1. The following PCR thermal profiles were used: 13 
holding stage at 50˚C for 2 minutes, followed by denaturation stage at 95˚C for 14 
10 minutes and then 40 cycles of 95˚C for 3 seconds and 60˚C for 15 seconds. 15 
Expression levels of each gene of interest were calculated using the ΔΔCt 16 
method, with expression normalised to the housekeeping gene ACT. 17 
 18 
Disinfection susceptibility testing 19 
For disinfection experiments, C. auris cells were standardised and prepared as 20 
described above in 10% FCS. Following the adhesion phase, non-adherent cells 21 
were removed through washing with PBS, before substrates were challenged 22 
with NaOCl at 1000 ppm (0.1%) for 5 and 10 minutes or 10000 ppm (1%) for 5 23 
minutes, with NaOCl diluted to working concentration in sterile water. Active 24 
agents were neutralised with 5% sodium thiosulphate (Fisher Scientific, 25 
Loughborough, UK) for 10 minutes, which has previously been shown to have 26 
no detrimental effects on C. auris viability [2]. Viable cells were both quantified 27 
immediately (Day 0) after neutralisation and 14 days after treatment using the 28 
colony counting technique as described above. 29 
 30 
 31 
Statistical analysis 32 
Data distribution, statistical analysis and graph production was performed using 33 
GraphPad Prism (version 8; La Jolla, CA, USA). A Kruskal-Wallis with post-hoc 34 
 6 
Dunn’s test was used to compare viable cell counts following desiccation. 1 
Student t-tests were used to compare cell recoveries following treatment. All 2 
experiments were performed in triplicate with differences in means were deemed 3 
significant if p<0.05. 4 
 5 
 6 
  7 
 7 
Results  1 
To test the theory of biofilm formation being employed as an endurance strategy 2 
of C. auris, we performed survival studies using two phenotypically distinct 3 
isolates based on their ability to form cellular aggregates. Similar to previous 4 
findings [7], C. auris was found to remain viable for at least two weeks within a 5 
dry environment, regardless of the organic material it was suspended in (Fig 1A). 6 
It was shown that aggregating cells survived considerably greater than their 7 
single-cell counter parts in PBS (>2.5 log CFU/mL; P < 0.001) and 10% FCS (>4 8 
log CFU/mL; P < 0.01). Although not deemed statistically significant, the 9 
aggregating isolate was shown to recover over 2-log CFU/mL more viable cells 10 
than the single-celled isolate when suspended in artificial saliva. These findings 11 
were reinforced microscopically (Fig 1B), where aggregates of viable C. auris 12 
cells (red fluorescence) could be seen after 14 days following suspension in 10% 13 
FBS, compared to a sparsely populated surface with single cells which were not 14 
viable (green fluorescence). When compared to C. glabrata and C. parapsilosis, 15 
the single celled C. auris isolate was shown to yield significantly less viable cells 16 
than C. glabrata in both PBS ( p<0.001) and AS (p<0.001). In addition, recovery 17 
of this isolate was also significantly less than that of C. parapsilosis in AS (P < 18 
0.01). The aggregative C. auris isolate also yielded significantly less viable cells 19 
than C. glabrata in AS (p<0.01), however >1 × 104 CFU/mL were recovered. 20 
Given these observed differences between singled celled and aggregating 21 
strains of C. auris, we then assessed the potential role biofilm characteristics to 22 
confer these findings. Using transcriptional analysis of a panel of biofilm 23 
associated genes including genes involved in drug resistance (Cdr1 and Mdr2), 24 
adhesion (Als5 and Hyr3) and extracellular matrix (Kre6 and Exg) were shown 25 
to be up-regulated in the aggregating C. auris phenotype (Fig 1C). Following 14 26 
days of starvation, both drug resistance genes were up-regulated by 1.6 and 2.6 27 
log2 fold change (Cdr1 and Mdr1 respectively) in the aggregative C. auris strain. 28 
In addition, the adhesin Als5 (2.8 log2 fold change) and the glucan production 29 
protein Kre6 (2.4 log2 fold change) also demonstrated increased expression in 30 
the aggregating strain compared to the single celled isolate. 31 
Given the propensity of C. auris to survive for prolonged periods, we next tested 32 
the survival ability of the organism post disinfection treatment. Quantification 33 
immediately after NaOCl treatment revealed that viable C. auris cells were 34 
 8 
recovered regardless of exposure time or concentration, with the aggregating 1 
strain consistently yielding significantly more viable quantities irrespective of 2 
treatment condition (Fig 2). Interestingly, despite previously exposure to 3 
1000ppm NaOCl for 5 min, greater than 1 × 103 CFU/mL of aggregating cells 4 
were recovered 14 days after treatment, compared to no recovery of viable 5 
single-celled equivalents (Fig 2A). However, following an increase in exposure 6 
time to 10 minutes (Fig 2B) or increase in NaOCl concentration to 10000ppm 7 
(Fig 2C), no viable C. auris cells were detected following 14 days’ incubation.  8 
 9 
 10 
 11 
 12 
  13 
 9 
Discussion 1 
Microorganisms employ various survival strategies to adapt and aid persistence 2 
in various ecological niches, enhancing the likelihood of effectively establishing 3 
transmission of infection. Here we show that cellular aggregation and expression 4 
of biofilm like characteristics of C. auris can facilitate prolonged survival after 5 
disinfection processes. Biofilm formation is typically associated with treatment 6 
failure and the recurrence of chronic infections, however, recent studies have 7 
suggested that it may also be employed as an environmental survival strategy 8 
of nosocomial pathogens. It has been previously shown that C. auris can survive 9 
and persist on various substrates including steel and plastic for up to four weeks 10 
[7]. In accordance with previous studies, we have demonstrated that viable C. 11 
auris cells can be recovered 14 days after inoculation across a number of 12 
biologically relevant soiling agents. The aggregating strain of C. auris was shown 13 
to have comparable survival properties to C. glabrata and C. parapsilosis in 14 
PBS, with C. glabrata recovering more viable cells in AS, likely due to the fact 15 
that C. glabrata is a commensal of the oral microbiota.    16 
 17 
The aggregation phenomena were first described by Borman et al (2016), and 18 
was shown to be to less virulent in vivo in comparison to a single celled isolate, 19 
likely due to an inability of these isolates to disseminate in host [6]. These 20 
phenotypes were initially hypothesised to be related with their associated 21 
genetic clade, however more recently, the ability to aggregate has been shown 22 
to be an inducible trait, with exposure to triazoles and echinocandins triggering 23 
single-celled isolates to form aggregates [9]. Although it is not as virulent, we 24 
have shown that an aggregative isolate has an enhanced survival capacity 25 
compared to a single-celled isolate and can continually persist for at least 2 26 
weeks after exposure to clinical concentrations of NaOCl. The effect of the 27 
reversible switch in C. auris with regards to disinfection remains unknown, it 28 
could however be speculated that induction of aggregate formation from the 29 
single celled phenotype could be employed as a mechanism to facilitate 30 
environmental survival.    31 
 32 
A recent study from Ledwoch and Maillard (2019) assessed the ability of a C. 33 
auris dry biofilm to withstand a panel of different disinfectants, such as peracetic 34 
 10 
acid and chlorine dioxide [10]. In support with this and our previous study [2], 1 
they showed that adherent C. auris cells could selectively tolerate various 2 
different biocides, as well as significant levels of transferability to new, sterile 3 
surfaces post-treatment. The authors model used the C. auris type strain DSMZ 4 
20192, which using traditional methodologies produces single cells, minimal 5 
levels of biofilm biomass and is susceptible to fluconazole (unpublished data). 6 
Therefore, it could be speculated that clinical isolates of this organism which can 7 
form more robust biofilms and have the capacity to aggregate, may have 8 
enhanced implications for both tolerance and transferability to treatment. 9 
 10 
To confirm a role for biofilms in facilitating environmental persistence, a panel of 11 
biofilm associated genes, chosen based upon our group’s previous 12 
transcriptional characterisation of C. auris biofilms were assessed [8]. These 13 
genes were highly expressed across both phenotypes, however comparative 14 
analysis revealed increased expression of approximately 2-fold of several of 15 
these genes which are involved in adhesion, extracellular matrix (ECM) 16 
production and efflux pumps. ECM production is a well-documented resistance 17 
mechanism in pathogenic fungal biofilms of Candida spp [8]. Increasing ECM 18 
production could provide the necessary protection for C. auris to survive 19 
extended periods of desiccation and retain viability following terminal 20 
disinfection. 21 
 22 
In conclusion, this study reveals a survival mechanism employed by this 23 
emerging pathogenic yeast which can facilitate its environmental persistence, 24 
even after being challenged with NaOCl. As we have previously suggested [2], 25 
the length of exposure to NaOCl is an important consideration, with increased 26 
exposure appearing the be more efficacious than an increased concentration. 27 
Further studies understanding the underlying biology associated with the 28 
aggregative phenotype and dry surface biofilms will allow the development of 29 
more effective infection, prevention and control measures to control C. auris 30 
within the nosocomial environment.  31 
 32 
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Figure 1. C. auris cellular aggregates display biofilm characteristics to aid 1 
environmental survival 2 
The ability of C. auris to survive for prolonged periods of time was compared to 3 
Candida glabrata and Candida parapsilosis (A). Fungal cells were allowed to 4 
adhere to plastic coverslips for 90 minutes in PBS, Artificial Saliva (AS) and 10% 5 
FCS before removing non adherent cells and media. Viable cells were quantified 6 
after 14 days using the miles and misra technique. C. auris communities initially 7 
adhered in 10% FBS and left for 14 days were imaged following staining with 8 
FUN-1 dye (B). Gene expression profiles of dry C. auris cells on day 0 and 14 9 
was used to confirm up-regulation of biofilm associated genes following survival. 10 
(C). Positive fold changes indicate more up-regulation in aggregating cells and 11 
genes more highly up-regulated in single-celled C. auris are represented by 12 
negative fold changes. 13 
 14 
Figure 2. Cellular aggregates of C. auris can survive for prolonged periods 15 
following NaOCl disinfection. 16 
Survival was also monitored after a 14-day period following disinfection 17 
challenge with NaOCl. Viable cells of aggregating and single-celled C. auris 18 
strains were enumerated by CFU quantification following treatments with NaOCl 19 
at 1000ppm for 5 (A) and 10 minutes (B) and at 10000ppm for 5 minutes (C). 20 
Experiments were performed in triplicate on three separate occasions (*, P < 21 
0.05 **, P < 0.01 comparing day 0; ###, P <0.0001 comparing day 14), ND – not 22 
detected. 23 
 24 
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